Jessica Regan
Virtus Therapeutics
Affiliations
Yale University
Technologies
Therapeutic
Indication
Neurodegenerative Disease
Executive Summary
View/DownloadAdditional Information
Minority-Led
Woman-Led
Virtus Therapeutics is developing a novel class of small molecules which stimulate Coenzyme A production to treat the debilitating, rare, pediatric disease, Pantothenate Kinase-Associated Neurodegeneration.
Program of
Initiated by
